ArticleMolecular and clinical oncology2020

Erratum: Oral intake of royal jelly improves anti-cancer effects and suppresses adverse events of molecular targeted therapy by regulating TNF-α and TGF-β in renal cell carcinoma: A preliminary study based on a randomized double-blind clinical trial.

Yasuyoshi Miyata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.